Pharma Industry News

New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell

Remdesivir could speed recovery of patients with COVID-19, but hydroxychloroquine may not be safe

Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]